,Title,SizeTEM (nm),Zeta potential,Incubation plasma concentration (v/v%),Incubation NP concentration (mg/L),Centrifugation speed (g),Centrifugation time （min）,Certrifugation temperature (℃),Dispersion medium pH,SizeDLS (nm),PDI,Incubation time (h),Incubation temperature (℃),Centrifugation repetitions,NP without modification_ADM105,NP without modification_ADM70,NP without modification_Ag,NP without modification_Au,NP without modification_Ca3(PO4)2,NP without modification_CaCO3,NP without modification_Chol-DC,NP without modification_Chol-PC,NP without modification_DC-Chol-DOPE,NP without modification_DOPC-DOPE-PEG-DSPC-DPPC,NP without modification_DOPG-DOPA,NP without modification_DOTAP,NP without modification_DOTAP-Chol,NP without modification_DOTAP-Chol-DPPC,NP without modification_DOTAP-Chol-DSPC,NP without modification_DOTAP-Chol-PC,NP without modification_DOTAP-DC-Chol,NP without modification_DOTAP-DOPC-DC-Chol-DOPE,NP without modification_DOTAP-DOPC-DC-Chol-DOPE/DOPE-PEG ,NP without modification_DOTAP-DOPE,NP without modification_DOTAP-DSPC-Chol,NP without modification_DOTAP/DNA,NP without modification_DOTAP/DOPC/DC-Chol/DOPE/DOPE-PEG2k,NP without modification_DOTAP:DOPC:DC-Chol:DOPE,NP without modification_DOTAP:DOPC:DC-Chol:DOPE-PEG,NP without modification_Fe3O4,NP without modification_HSPC-Chol,NP without modification_HSPC-Chol-DSPE,NP without modification_HSPC-Chol-DSPE-PEG20000,NP without modification_HSPC-DSPG-Chol,NP without modification_LPD,NP without modification_MWCNT,NP without modification_PS,NP without modification_PSOSO3,NP without modification_SWCNT,NP without modification_Shingosine-Chol-DSPC,NP without modification_Si,NP without modification_SiO2,NP without modification_TiO2,NP without modification_zeolite,Surface modification_AC,Surface modification_AHT,Surface modification_AUT,Surface modification_BCN,Surface modification_BPEI,Surface modification_CA,Surface modification_CALNN,Surface modification_CFGAILS,Surface modification_CIT,Surface modification_COOH,Surface modification_CTAB,Surface modification_CVVIT,Surface modification_DDT,Surface modification_DTNB,Surface modification_EMT,Surface modification_F127,Surface modification_FAU,Surface modification_HDA,Surface modification_LA,Surface modification_MAA,Surface modification_MBA,Surface modification_MES,Surface modification_MHA,Surface modification_MHDA,Surface modification_MPA,Surface modification_MSA,Surface modification_MUA,Surface modification_MUEG4,Surface modification_MUTA,Surface modification_NH2,Surface modification_NT,Surface modification_OAOA,Surface modification_ODA,Surface modification_OSO3,Surface modification_PAH-SH,Surface modification_PC,Surface modification_PEEP,Surface modification_PEG,Surface modification_PEI-SH,Surface modification_PVA,Surface modification_PVP,Surface modification_SA,Surface modification_SPP,Surface modification_SiO2,Surface modification_T20,Surface modification_TP,Surface modification_TiO2,Surface modification_amino acid,Surface modification_none,Surface modification_pDNA,Incubation protein source_FBS,Incubation protein source_HP,Incubation protein source_HS,Incubation protein source_RP,Incubation protein source_RS,NP type_carbon,NP type_liposome,NP type_metal,NP type_other,NP shape_powder,NP shape_rod,NP shape_sheet,NP shape_sphere,NP shape_star,NP shape_tube,Dispersion medium_PBS,Dispersion medium_buffer,Dispersion medium_cell culture,Dispersion medium_plasma,Dispersion medium_water,Incubation culture_DMEM,Incubation culture_buffer,Incubation culture_water,Modification type_Anionic,Modification type_Cationic,Modification type_Neutral,P67936
40,Do plasma proteins distinguish between liposomes of varying charge density?,102.0,54.3,50.0,500.0,15000,10,25,7.0,102.0,0.243,1.0,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,1.04755
53,Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells,116.9,18.3,50.0,500.0,14000,15,25,7.0,116.9,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.406330852
327,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,30.2,-10.0,90.0,60.0,15300,20,4,7.4,31.0,0.104,30.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.07
415,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,129.0,-8.0,90.0,60.0,15300,20,4,7.4,180.0,0.007,0.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.05
370,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,144.8,-18.0,90.0,60.0,15300,20,4,7.4,148.0,0.004,120.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.04
113,The liposome-protein corona in mice and humans and its implications for in vivo delivery,152.85,-13.74,50.0,500.0,14000,15,25,7.4,152.85,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.117921586
396,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,129.0,-28.0,90.0,60.0,15300,20,4,7.4,133.0,0.006,15.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.03
105,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",119.2,56.3,50.0,500.0,14000,15,25,7.4,119.2,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.516912435
399,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,129.0,-28.0,90.0,60.0,15300,20,4,7.4,133.0,0.006,120.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.02
97,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,20.08,-24.97,66.0,0.02101,19000,20,4,7.4,56.6,0.126944444,1.0,37,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.008
375,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,141.0,-21.0,90.0,60.0,15300,20,4,7.4,141.0,0.002,15.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.04
439,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-9.0,90.0,60.0,15300,20,4,7.4,75.0,0.051,60.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.02
395,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,129.0,-28.0,90.0,60.0,15300,20,4,7.4,133.0,0.006,5.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.03
52,Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells,118.7,15.5,50.0,500.0,14000,15,25,7.0,118.7,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.586441473
419,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,129.0,-8.0,90.0,60.0,15300,20,4,7.4,180.0,0.007,5.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.03
103,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",85.6,55.6,50.0,500.0,14000,15,25,7.4,85.6,0.126944444,1.0,37,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.083473151
410,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,141.0,-6.0,90.0,60.0,15300,20,4,7.4,158.0,0.007,15.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.04
84,In vivo protein corona patterns of lipid nanoparticles,185.0,-20.5,100.0,500.0,1800,10,4,7.4,266.0,0.373,0.166666667,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0.64
324,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,30.2,-10.0,90.0,60.0,15300,20,4,7.4,31.0,0.104,2.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.04
43,Do plasma proteins distinguish between liposomes of varying charge density?,109.0,56.3,50.0,500.0,15000,10,25,7.0,109.0,0.212,1.0,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,1.032597016
114,The liposome-protein corona in mice and humans and its implications for in vivo delivery,208.0,-15.7,50.0,500.0,14000,15,25,7.4,208.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.071835898
432,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,30.2,-9.0,90.0,60.0,15300,20,4,7.4,72.0,0.085,5.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.07
333,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,27.2,-14.0,90.0,60.0,15300,20,4,7.4,69.0,0.068,2.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.08
377,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,141.0,-21.0,90.0,60.0,15300,20,4,7.4,141.0,0.002,60.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.03
394,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,129.0,-28.0,90.0,60.0,15300,20,4,7.4,133.0,0.006,2.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.05
344,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-15.0,90.0,60.0,15300,20,4,7.4,33.0,0.045,0.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.1
486,Surface chemistry and serum type both determine the nanoparticle-protein corona,246.3,34.0,50.0,500.0,18000,15,25,7.4,246.3,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.18205481
533,Time evolution of nanoparticle-protein corona in human plasma: Relevance for targeted drug delivery,130.0,55.0,50.0,500.0,14000,15,25,7.0,130.0,0.2,0.5,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.17
326,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,30.2,-10.0,90.0,60.0,15300,20,4,7.4,31.0,0.104,15.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.22
